Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effects of Short-Term High-Concentration Formaldehyde Exposure on Respiratory Microecology and Inflammatory Markers in Healthy Adults (FORM-Resp)

11 novembre 2026 aggiornato da: First Affiliated Hospital of Ningbo University

Prospective Self-Control Study on the Effects of Short-Term High-Concentration Formaldehyde Exposure on Respiratory Microecology and Inflammatory Markers in Healthy Adults

Formaldehyde exposure is common in some occupational environments, including anatomy laboratories, and may affect respiratory health. However, the early biological changes caused by short-term high-concentration formaldehyde exposure remain unclear.

This prospective self-controlled observational study aims to evaluate the effects of short-term high-concentration formaldehyde exposure on respiratory microecology, inflammatory biomarkers, and acute respiratory symptoms in healthy adults. Participants will be monitored before and after formaldehyde exposure, and changes in airway-related biological indicators will be assessed through biological samples and clinical evaluations.

The findings of this study may provide human evidence for exposure control, ventilation improvement, protective measures, and health risk assessment in environments with formaldehyde exposure.

Panoramica dello studio

Stato

Attivo, non reclutante

Condizioni

Intervento / Trattamento

Descrizione dettagliata

This is a prospective self-controlled observational study designed to investigate early respiratory biological responses associated with short-term high-concentration formaldehyde exposure in healthy adults.

Participants will be healthy medical students who enter an anatomy laboratory and experience short-term formaldehyde exposure during anatomy training. Each participant will serve as his or her own control. Biological samples and clinical information will be collected at multiple time points, including before exposure (T0), 6 hours after exposure (T1), and 24 hours after exposure (T2).

The study will evaluate changes in respiratory microecological composition, local inflammatory responses, systemic inflammatory and oxidative stress-related biomarkers, and acute irritation symptoms after formaldehyde exposure. Formaldehyde exposure levels, exposure duration, and protective measures will also be recorded to explore the relationship between exposure intensity and biological responses.

At T0, baseline information, respiratory symptoms, induced sputum samples, peripheral blood samples, and other relevant assessments will be collected. During and after exposure, environmental formaldehyde concentrations and exposure-related information will be monitored. At T1 and T2, repeated assessments will be performed, including symptom evaluation, induced sputum collection, peripheral blood collection, inflammatory biomarker detection, and respiratory microecological analysis.

This study aims to provide human-based evidence regarding early respiratory effects of short-term formaldehyde exposure and may contribute to improving ventilation strategies, occupational protection measures, exposure duration control, and health risk assessment in formaldehyde-exposed environments.

Tipo di studio

Osservativo

Iscrizione (Stimato)

65

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Zhejiang
      • Ningbo, Zhejiang, Cina, 315211
        • Wang Changlai Building, East Campus, Ningbo University

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 35 anni (Adulto)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Healthy adult medical students who attend anatomy laboratory courses involving short-term formaldehyde exposure will be recruited. Participants will undergo prospective self-controlled observation before and after exposure. Changes in respiratory microbiome composition, airway inflammatory biomarkers, systemic inflammatory and oxidative stress indicators, and acute irritation symptoms after formaldehyde exposure will be evaluated.

Descrizione

Inclusion Criteria:

  • 1: Aged 18-35 years old

    2: The healthy medical students who participated in the anatomy course for the first time had no systematic formaldehyde / formalin occupational or teaching exposure in the past 6 months.

    3: Health examination, and no history of chronic respiratory diseases ( such as asthma, active allergic rhinitis, chronic sinusitis, bronchiectasis, interstitial pulmonary fibrosis, etc. )

    4: There were no acute upper respiratory tract infection, fever, COVID-19 or influenza-like symptoms in the past 4 weeks.

    5: There was no use of antibiotics, glucocorticoids, bronchodilators, and immunomodulatory drugs in the past 4 weeks.

    6: There was no obvious eye, nose, throat irritation or lower respiratory symptoms at baseline, and was able to cooperate with the completion of three induced sputum, two peripheral blood collections and related follow-up evaluations

    7: Voluntary to participate in and sign a written informed consent.

Exclusion Criteria:

  • 1: Have asthma, COPD, bronchiectasis, interstitial lung disease, chronic sinusitis, active allergic rhinitis or other chronic airway inflammatory diseases

    2: Acute upper respiratory tract infection, fever, COVID-19 or influenza-like symptoms, or active allergies / obvious seasonal allergies occurred in the past 4 weeks

    3: Used antibiotics, systemic or inhaled corticosteroids, bronchodilators, immunomodulatory drugs in the past 4 weeks

    4: Current smoking, use of e-cigarettes or hookah, smoking history in the past six months, or obvious high exposure to second-hand smoke in the past four weeks

    5: Exposure to non-daily formaldehyde, formalin or other strong irritant chemicals in the past 4 weeks

    6: Have a clear history of allergy to formaldehyde or other chemicals, or intolerance to hypertonic saline atomization

    7: Pregnant or lactating women

    8: Severe cardiovascular and cerebrovascular diseases, coagulation dysfunction, recent hemoptysis, severe hypertension, recent ophthalmic surgery, epilepsy requiring drug treatment, severe arrhythmia or other conditions not suitable for induced sputum operation

    9: All follow-ups and biological sample collections could not be completed for personal reasons, or researchers considered it inappropriate to continue participating in the study

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: RETROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Intervento / Trattamento
Formaldehyde Exposure Cohort

Healthy adults receiving anatomy laboratory courses were enrolled in this prospective self-controlled observational study. Participants were exposed to short-term formaldehyde released from fixed tissue specimens in the anatomy laboratory and were evaluated before and after exposure.

Short-term high-concentration formaldehyde exposure during anatomy laboratory courses

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change From Baseline in the Shannon Diversity Index of Induced Sputum Microbiota
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

The Shannon Diversity Index of induced sputum microbiota will be measured using 16S ribosomal ribonucleic acid gene sequencing. The index evaluates microbial alpha diversity by accounting for both taxon richness and evenness. It has a minimum value of 0 and no fixed maximum value, with higher values indicating greater microbial diversity. Change from baseline will be calculated as the value at each post-exposure time point minus the baseline value.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change From Baseline in the Chao1 Richness Index of Induced Sputum Microbiota
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

The Chao1 Richness Index of induced sputum microbiota will be measured using 16S ribosomal ribonucleic acid gene sequencing. The index estimates the number of microbial taxa in a sample. It has a minimum value of 0 and no fixed maximum value, with higher values indicating greater estimated microbial richness. Change from baseline will be calculated as the value at each post-exposure time point minus the baseline value.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
R-Squared Value From Permutational Multivariate Analysis of Variance of Induced Sputum Microbial Community Structure Across Sampling Time Points
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Beta diversity of induced sputum microbiota will be evaluated using principal coordinates analysis and permutational multivariate analysis of variance. The primary reported measure will be the R-squared value from the permutational multivariate analysis of variance, representing the proportion of variation in microbial community structure explained by sampling time. Values range from 0 to 1, with higher values indicating that sampling time explains a greater proportion of variation in microbial community structure.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Induced Sputum Neutrophil Percentage
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

The percentage of neutrophils in induced sputum will be determined by differential cell counting of stained cytospin slides. Values range from 0% to 100%, with higher values indicating a greater proportion of neutrophils. Change from baseline will be calculated as the percentage at each post-exposure time point minus the baseline percentage and reported in percentage points.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in the Percentage of Neutrophils in Induced Sputum
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

The percentage of neutrophils in induced sputum will be determined by differential cell counting of stained cytospin slides. Values range from 0% to 100%, with higher values indicating a greater proportion of neutrophils. Change from baseline will be calculated as the percentage at each post-exposure time point minus the baseline percentage.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in the Percentage of Macrophages and Monocytes in Induced Sputum
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

The percentage of macrophages and monocytes in induced sputum will be determined by differential cell counting of stained cytospin slides. Values range from 0% to 100%, with higher values indicating a greater proportion of macrophages and monocytes. Change from baseline will be calculated as the percentage at each post-exposure time point minus the baseline percentage.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in the Percentage of Lymphocytes in Induced Sputum
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

The percentage of lymphocytes in induced sputum will be determined by differential cell counting of stained cytospin slides. Values range from 0% to 100%, with higher values indicating a greater proportion of lymphocytes. Change from baseline will be calculated as the percentage at each post-exposure time point minus the baseline percentage.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in the Percentage of Eosinophils in Induced Sputum
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

The percentage of eosinophils in induced sputum will be determined by differential cell counting of stained cytospin slides. Values range from 0% to 100%, with higher values indicating a greater proportion of eosinophils. Change from baseline will be calculated as the percentage at each post-exposure time point minus the baseline percentage.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in the Percentage of Bronchial Epithelial Cells in Induced Sputum
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

The percentage of bronchial epithelial cells in induced sputum will be determined by differential cell counting of stained cytospin slides. Values range from 0% to 100%, with higher values indicating a greater proportion of bronchial epithelial cells. Change from baseline will be calculated as the percentage at each post-exposure time point minus the baseline percentage.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Interleukin 1 Beta Concentration in Induced Sputum Supernatant
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Interleukin 1 beta concentration will be measured in induced sputum supernatant. Change from baseline will be calculated as the concentration at each post-exposure time point minus the baseline concentration.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Interleukin 6 Concentration in Induced Sputum Supernatant
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Interleukin 6 concentration will be measured in induced sputum supernatant. Change from baseline will be calculated as the concentration at each post-exposure time point minus the baseline concentration.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Interleukin 8 Concentration in Induced Sputum Supernatant
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Interleukin 8 concentration will be measured in induced sputum supernatant. Change from baseline will be calculated as the concentration at each post-exposure time point minus the baseline concentration.

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Tumor Necrosis Factor Alpha Concentration in Induced Sputum Supernatant
Lasso di tempo: Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Tumor necrosis factor alpha concentration will be measured in induced sputum supernatant. Change from baseline will be calculated as the concentration at each post-exposure time point minus the baseline concentration

Baseline within 48 hours before exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in C-Reactive Protein Concentration in Peripheral Blood
Lasso di tempo: Baseline within 48 hours before exposure and 24 hours plus or minus 1 hour after exposure

C-reactive protein concentration will be measured in peripheral blood. Change from baseline will be calculated as the concentration 24 hours after exposure minus the baseline concentration.

Baseline within 48 hours before exposure and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Interleukin 6 Concentration in Peripheral Blood
Lasso di tempo: Baseline within 48 hours before exposure and 24 hours plus or minus 1 hour after exposure

Interleukin 6 concentration will be measured in peripheral blood. Change from baseline will be calculated as the concentration 24 hours after exposure minus the baseline concentration.

Baseline within 48 hours before exposure and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Tumor Necrosis Factor Alpha Concentration in Peripheral Blood
Lasso di tempo: Baseline within 48 hours before exposure and 24 hours plus or minus 1 hour after exposure

Tumor necrosis factor alpha concentration will be measured in peripheral blood. Change from baseline will be calculated as the concentration 24 hours after exposure minus the baseline concentration.

Baseline within 48 hours before exposure and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Malondialdehyde Concentration in Peripheral Blood
Lasso di tempo: Baseline within 48 hours before exposure and 24 hours plus or minus 1 hour after exposure

Malondialdehyde concentration will be measured in peripheral blood as a marker of oxidative stress. Change from baseline will be calculated as the concentration 24 hours after exposure minus the baseline concentration.

Baseline within 48 hours before exposure and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Eye Irritation Score Assessed Using a Visual Analog Scale
Lasso di tempo: Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Eye irritation will be rated by each participant using a visual analog scale ranging from 0 to 10, where 0 indicates no symptoms and 10 indicates the most severe symptoms imaginable. Higher scores indicate greater symptom severity. Change from baseline will be calculated as the score at each post-exposure assessment minus the baseline score.

Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Nasal Irritation Score Assessed Using a Visual Analog Scale
Lasso di tempo: Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Nasal irritation will be rated by each participant using a visual analog scale ranging from 0 to 10, where 0 indicates no symptoms and 10 indicates the most severe symptoms imaginable. Higher scores indicate greater symptom severity. Change from baseline will be calculated as the score at each post-exposure assessment minus the baseline score.

Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Throat Irritation Score Assessed Using a Visual Analog Scale
Lasso di tempo: Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Throat irritation will be rated by each participant using a visual analog scale ranging from 0 to 10, where 0 indicates no symptoms and 10 indicates the most severe symptoms imaginable. Higher scores indicate greater symptom severity. Change from baseline will be calculated as the score at each post-exposure assessment minus the baseline score.

Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Cough Score Assessed Using a Visual Analog Scale
Lasso di tempo: Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Cough will be rated by each participant using a visual analog scale ranging from 0 to 10, where 0 indicates no symptoms and 10 indicates the most severe symptoms imaginable. Higher scores indicate greater symptom severity. Change from baseline will be calculated as the score at each post-exposure assessment minus the baseline score.

Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure
Change From Baseline in Chest Tightness Score Assessed Using a Visual Analog Scale
Lasso di tempo: Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Chest tightness will be rated by each participant using a visual analog scale ranging from 0 to 10, where 0 indicates no symptoms and 10 indicates the most severe symptoms imaginable. Higher scores indicate greater symptom severity. Change from baseline will be calculated as the score at each post-exposure assessment minus the baseline score.

Baseline within 48 hours before exposure, immediately after exposure, 6 hours plus or minus 1 hour after exposure, and 24 hours plus or minus 1 hour after exposure

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Investigatore principale: Chao Cao, Ningbo University Affiliated First Hospital

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

11 ottobre 2026

Completamento primario (Effettivo)

1 novembre 2026

Completamento dello studio (Stimato)

30 giugno 2027

Date di iscrizione allo studio

Primo inviato

14 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

11 novembre 2026

Primo Inserito (Effettivo)

17 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 2026-R311-01

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

INDECISO

Descrizione del piano IPD

The plan for sharing individual participant data (IPD) has not yet been determined. Any future data sharing will be considered in accordance with ethical requirements, participant privacy protection, and institutional policies.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .